arsenic has been researched along with ng-nitroarginine methyl ester in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beall, HD; Bunderson, M; Coffin, JD; Pereira, F; Schneider, MC; Shaw, PK | 1 |
| Alexandre, J; Annereau, M; Batteux, F; Chéreau, C; Dauphin, A; Goldwasser, F; Lemare, F; Mongaret, C; Nicco, C; Thomas-Schoemann, A; Weill, B | 1 |
2 other study(ies) available for arsenic and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Manganese enhances peroxynitrite and leukotriene E4 formation in bovine aortic endothelial cells exposed to arsenic.
Topics: Animals; Aorta; Arsenic; Arsenites; Cattle; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Endothelium, Vascular; Environmental Pollutants; Enzyme Inhibitors; Leukotriene E4; Manganese; NG-Nitroarginine Methyl Ester; Peroxynitrous Acid; Sodium Compounds; Tyrosine | 2006 |
Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer.
Topics: Animals; Arsenic Trioxide; Arsenicals; CD8-Positive T-Lymphocytes; Colonic Neoplasms; Enzyme Inhibitors; Female; Fluorescein; Fluoresceins; Humans; Immunotherapy, Adoptive; Lymphocyte Activation; Lymphocyte Depletion; Metalloporphyrins; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidative Stress; Oxides; Reactive Nitrogen Species; Reactive Oxygen Species; Superoxide Dismutase; T-Lymphocytes, Regulatory | 2012 |